李文輝博士
- 基本信息
- 教育經歷
- 工作經歷
- 研究概述
- 發表文章

李文輝 博士
北京生命科學研究所資深研究員
Wenhui Li, Ph.D. Investigator, NIBS, Beijing, China
Phone:010-80726688-8580
Fax: 010-80726689
E-mail:liwenhui@nibs.ac.cn
教育經歷
Education
1994 |
蘭州大學醫學院 醫學學士學位 |
|
|
1997 |
蘭州生物制品研究所 免疫學碩士學位 |
|
Lanzhou Institute of Biological Products |
2001 |
中國協和醫科大學中國醫學科學院 病原生物學博士學位 |
|
|
工作經歷
Professional Experience
2015.3- |
北京生命科學研究所資深研究員 |
|
Investigator, National Institute of Biological Sciences, Beijing |
||
2007.10-2015.2 |
北京生命科學研究所研究員 |
|
Assistant Investigator, National Institute of Biological Sciences, Beijing |
||
2004.6-2007.9 |
哈佛大學醫學院 Instructor |
|
Harvard Medical School, Boston |
||
2001.9-2004.5 |
哈佛大學醫學院 博士后 |
|
Postdoctoral Fellow, Harvard Medical School, Boston |
研究概述
Research Description
本實驗室的研究興趣集中于重要病毒感染的分子機制及其防治。近年來,我們主要致力于乙肝病毒(HBV)研究。乙型肝炎是危害人類健康的嚴重傳染病。全球估計有HBV感染者2.4億人,其中我國約有9300萬人。慢性HBV感染是導致肝硬化、肝癌的重要病因。丁型肝炎病毒(HDV)是HBV的衛星病毒,在所有HBV感染者中,約有1500萬人同時感染HDV。我們發現HBV及HDV感染肝細胞的關鍵受體是鈉離子-牛磺膽酸共轉運蛋白(NTCP);穩定表達人NTCP的HepG2細胞系(HepG2-NTCP)已成為HBV相關基礎病毒學研究和抗病毒藥物研發的重要平臺。目前,對乙肝感染的科學研究及藥物開發已進入一個充滿生機的新時代。本實驗室綜合運用病毒學,生物化學,免疫學,化學生物學等多學科方法深入剖析HBV及HDV感染過程的分子基礎,以幫助理解其病理機制。我們也希望研發新的抗病毒藥物,為最終有效解除患者的病痛而努力。此外,我們也與相關實驗室合作研究NTCP/膽酸等分子在感染及機體代謝過程中的相關作用。
Our laboratory is interested in studying molecular mechanisms of viral infection and developing antiviral interventions. We’ve been focused on hepatitis B virus (HBV) in recent years. HBV infection remains a public health problem. About 240 million people are infected by HBV worldwide and among them 93 million are in China. Chronic HBV infection is a major cause of cirrhosis and hepatocellular carcinoma. Hepatitis D virus (HDV), a satellite of HBV, infects 15 million people among those infected by HBV. We identified sodium taurocholatecotransporting polypeptide (NTCP), a liver bile acid transporter, as a crucial receptor for viral infection of HBV and HDV; Human hepatoma HepG2 cell complemented with human NTCP (HepG2-NTCP) has become an important platform for studying HBV basic virology and developing antivirals. The field is entering into a new era of vibrant research of the virus and towards developing a cure for the infection. Our laboratory combines virology, biochemistry, immunology, and chemical biology to investigate molecular mechanisms of HBV/HDV infection. Our research will help to elucidate the pathogenesis of the viruses and to develop new drugs for the treatment of the infection and associated diseases. We also collaborate with other colleagues to study NTCP/bile acids for their roles in the infection and related metabolic process.
發表文章
Publications:
1. |
He, W.,B.Ren, F.Mao,Z.Jing,Y.Li,Y.Liu,B.Peng, H. Yan,Y.Qi,Y.Sun, J-T.Guo,J.Sui,F.Wang, andW.Li*. Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide.PLOS Pathog, 10.1371/journal.ppat.1004840, 2015. |
2. |
Yan, H., B. Peng, Y. Liu, G. Xu, W. He, B. Ren, Z. Jing, J. Sui, and W. Li*. Viral entry of hepatitis B and d viruses and bile salts transportation share common molecular determinants on sodium taurocholatecotransporting polypeptide. Journal of virology, 88(6): p. 3273-84, 2014. |
3. |
Sun, Y*., Y. Qi, C. Liu, W. Gao, P. Chen, L. Fu, B. Peng, H. Wang, Z. Jing, G. Zhong, and W. Li*. Nonmuscle myosin heavy chain IIA is a critical factor contributing to the efficiency of early infection of severe fever with thrombocytopenia syndrome virus. Journal of virology, 88(1):237-48, 2014. |
4. |
Xu, G., Z. Gao, W. He, Y. Ma, X. Feng, T. Cai, F. Lu, L. Liu, and W. Li*. microRNA expression in hepatitis B virus infected primary treeshrew hepatocytes and the independence of intracellular miR-122 level for de novo HBV infection in culture. Virology, 448: 247-54, 2014. |
5. |
Zhong, G., H. Yan, H. Wang, W. He, Z. Jing, Y. Qi, L. Fu, Z. Gao, Y. Huang, G. Xu, X. Feng, J. Sui, and W. Li*. Sodium taurocholatecotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytes. Journal of virology, 87(12): 7176-84, 2013. |
6. |
Yan, H., B. Peng, W. He, G. Zhong, Y. Qi, B. Ren, Z. Gao, Z. Jing, M. Song, G. Xu, J. Sui, and W. Li*. Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholatecotransporting polypeptide. Journal of virology, 87(14): 7977-91, 2013. |
7. |
Liu, F., M. Campagna, Y. Qi, X. Zhao, F. Guo, C. Xu, S. Li, W. Li, T.M. Block, J. Chang, and J.T. Guo*. Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNAminichromosomes.PLoSPathog, 9(9): p. e1003613, 2013. |
8. |
Lin, S., H. Yan, L. Li, M. Yang, B. Peng, S. Chen, W. Li*, and P.R. Chen*. Site-Specific Engineering of Chemical Functionalities on the Surface of Live Hepatitis D Virus. AngewandteChemie International Edition, 52(52): 13970-13974, 2013. |
9. |
Jemielity, S., J.J. Wang, Y.K. Chan, A.A. Ahmed, W. Li, S. Monahan, X. Bu, M. Farzan, G.J. Freeman, D.T. Umetsu, R.H. Dekruyff, and H. Choe*. TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine. PLoSPathog, 9(3): e1003232, 2013. |
10. |
Yan, H., G. Zhong, G. Xu, W. He, Z. Jing, Z. Gao, Y. Huang, Y. Qi, B. Peng, H. Wang, L. Fu, M. Song, P. Chen, W. Gao, B. Ren, Y. Sun, T. Cai, X. Feng, J. Sui, and W. Li*. Sodium taurocholatecotransporting polypeptide is a functional receptor for human hepatitis B and D virus.eLife, 1: e00049, 2012. |
11. |
Chen, P., Z. Song, Y. Qi, X. Feng, N. Xu, Y. Sun, X. Wu, X. Yao, Q. Mao, X. Li, W. Dong, X. Wan, N. Huang, X. Shen, Z. Liang, and W. Li*. Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J BiolChem, 287(9): 6406-20, 2012. |
12. |
Huang, Z., Y. Feng, D. Chen, X. Wu, S. Huang, X. Wang, X. Xiao, W. Li, N. Huang, L. Gu, G. Zhong, and J. Chai*. Structural basis for activation and inhibition of the secreted chlamydia protease CPAF. Cell Host Microbe, 4(6):529-42, 2008. |
13. |
Huang, I.-C., W. Li, J. Sui, W. Marasco, H. Choe, and M. Farzan*. Influenza A virus neuraminidase limits viral superinfection. Journal of virology, 82(10): 4834-4843, 2008. |
14. |
Radoshitzky, S.R., J. Abraham, C.F. Spiropoulou, J.H. Kuhn, D. Nguyen, W. Li, J. Nagel, P.J. Schmidt, J.H. Nunberg, N.C. Andrews, M. Farzan, and H. Choe*. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature, 446(7131): p. 92-6, 2007. |
15. |
Li, W., J. Sui, I. Huang, J.H. Kuhn, S.R. Radoshitzky, W.A. Marasco, H. Choe, and M. Farzan*. The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2. Virology, 367(2): 367-374, 2007. |
16. |
Zhang, L., F. Zhang, W. Yu, T. He, J. Yu, C.E. Yi, L. Ba, W. Li, M. Farzan, Z. Chen, K.Y. Yuen, and D. Ho*. Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. J Med Virol, 78(1): 1-8, 2006. |
17. |
Li, F., M. Berardi, W. Li, M. Farzan, P.R. Dormitzer, and S.C. Harrison*. Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain. Journal of virology, 80(14): 6794-6800, 2006. |
18. |
Kuhn, J.H., S.R. Radoshitzky, A.C. Guth, K.L. Warfield, W. Li, M.J. Vincent, J.S. Towner, S.T. Nichol, S. Bavari, H. Choe, M.J. Aman, and M. Farzan*. Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J BiolChem, 2006. 281(23): 15951-8. |
19. |
Huang, I.-C., B.J. Bosch, F. Li, W. Li, K.H. Lee, S. Ghiran, N. Vasilieva, T.S. Dermody, S.C. Harrison, and P.R. Dormitzer*. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J BiolChem, 281(6): 3198-3203, 2006. |
20. |
He, Y., J. Li, W. Li, S. Lustigman, M. Farzan, and S. Jiang*. Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein. Journal of Immunology, 176(10): 6085-6092, 2006. |
21. |
Sui, J., W. Li, A. Roberts, L.J. Matthews, A. Murakami, L. Vogel, S.K. Wong, K. Subbarao, M. Farzan, and W.A. Marasco*. Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants. Journal of virology, 79(10): 5900-5906, 2005. |
22. |
Li, W., C. Zhang, J. Sui, J.H. Kuhn, M.J. Moore, S. Luo, S.K. Wong, I.C. Huang, K. Xu, N. Vasilieva, A. Murakami, Y. He, W.A. Marasco, Y. Guan, H*. Choe*, and M. Farzan*. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J, 24(8): 1634-43, 2005. |
23. |
Li, F., W. Li, M. Farzan, and S.C. Harrison*. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science, 309(5742): 1864-1868, 2005. |
24. |
Choe, H., M.J. Moore, C.M. Owens, P.L. Wright, N. Vasilieva, W. Li, A.P. Singh, R. Shakri, C.E. Chitnis, and M. Farzan*. Sulphatedtyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC). Molecular microbiology, 55(5): 1413-1422, 2005. |
25. |
Wong, S.K., W. Li, M.J. Moore, H. Choe, and M. Farzan*. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J Biol Chem,279(5): 3197-3201, 2004. |
26. |
Sui, J., W. Li, A. Murakami, A. Tamin, L.J. Matthews, S.K. Wong, M.J. Moore, A.S. Tallarico, M. Olurinde, H. Choe, L.J. Anderson, W.J. Bellini, M. Farzan, and W.A. Marasco*. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl AcadSci U S A, 101(8): 2536-41, 2004. |
27. |
Moore, M.J., T. Dorfman, W. Li, S.K. Wong, Y. Li, J.H. Kuhn, J. Coderre, N. Vasilieva, Z. Han, T.C. Greenough, M. Farzan, and H. Choe*. Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2. Journal of virology, 78(19):10628-35, 2004. |
28. |
Li, W., T.C. Greenough, M.J. Moore, N. Vasilieva, M. Somasundaran, J.L. Sullivan, M. Farzan*, and H. Choe*. Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2. Journal of virology, 78(20):11429-11433, 2004. |
29. |
He, Y., Y. Zhou, S. Liu, Z. Kou, W. Li, M. Farzan, and S. Jiang*. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochemical and biophysical research communications, 324(2): 773-781, 2004. |
30. |
Li, W., M.J. Moore, N. Vasilieva, J. Sui, S.K. Wong, M.A. Berne, M. Somasundaran, J.L. Sullivan, K. Luzuriaga, T.C. Greenough, H. Choe*, and M. Farzan*. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature, 426(6965): 450-454, 2003. |
31. |
Choe, H., W. Li, P.L. Wright, N. Vasilieva, M. Venturi, C.C. Huang, C. Grundner, T. Dorfman, M.B. Zwick, L. Wang, E.S. Rosenberg, P.D. Kwong, D.R. Burton, J.E. Robinson, J.G. Sodroski, and M. Farzan*. Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120. Cell, 114(2): 161-170, 2003. |
32. |
Farzan, M., S. Chung, W. Li, N. Vasilieva, P.L. Wright, C.E. Schnitzler, R.J. Marchione, C. Gerard, N.P. Gerard, and J. Sodroski*. Tyrosine-sulfated peptides functionally reconstitute a CCR5 variant lacking a critical amino-terminal region. J BiolChem, 277(43):40397-40402, 2002. |
33. |
Li, W.,Y. Zhang,J.Sui, S. Wang *. Combined immunization of DNA vaccine and replication-defective recombinant adenovirus bearing rabies glycoprotein gene induces immune response against rabies virus. Chin J Micro and Immuno, 22(4): 403-406,2002 (in Chinese) |
34. |
Sui, J.,W.Li, X.Jiang, Y. He,Z. Song*. Highly Efficient Expression and Functional Studies of An Anti-KG1a Cell scFv 5C1 derived from Phage Display Antibody Library. Chin J Micro and Immuno, 21(4) : 437~441,2001 (in Chinese) |
35. |
Li, W., Y. Zhang, S. Wang*, L. Liu. Immune response of mice against replication-defective recombinant adenovirus containing glycoprotein gene of rabies 3aG strain. Chin J Exp and Clin Viro,15(1):35-39,2001 (in Chinese) |
36. |
Li, W., S. Wang*, Y. Zhang, L.Liu. Construction of cloned recombinant adenovirus genome by homologous recombination in Escherichia coli. Chin JBiochem and Mole Bio, 16(3):346-35,2000 (in Chinese) |
37. |
Zhang, X., Y. Zhang, W. Li, S. Wang*.Expression of glycoprotein gene of the rabies virus 3aG strain by E-3 deleted adenovirus recombinant. Chin J of Exp and ClinViro, 14 (3).281-284, 2000 (in Chinese) |
受邀綜述
Invited Review Articles: